Highly Pathogenic H5n1 Avian Influenza

HHS has terminated contracts with Moderna worth more than $700 million that were meant to fund the company’s development of pre-pandemic influenza vaccines, including the company’s H5 bird flu vaccine candidate.

Three bovine veterinary practitioners had evidence prior infection with highly pathogenic H5N1 avian influenza despite having no apparent contact with infected cows, according to a study published in MMWR.

A child in California suspected to have highly pathogenic H5N1 avian influenza consumed raw milk before experiencing symptoms, officials said.